Lainie P. Martin, M.D., Joins Fox Chase Cancer Center's Department of Medical Oncology
PHILADELPHIA (August 9, 2006) - Lainie P. Martin, MD, has joined Fox Chase Cancer Center's medical oncology department as an attending physician. Dr. Martin's clinical interests include ovarian, endometrial and cervical cancers and investigative therapy.
Dr. Martin recently completed a Fox Chase/Temple University fellowship in hematology-oncology. She earned her bachelor's degree at the University of Pennsylvania and completed her M.D. at Temple University School of Medicine in 1999. Dr. Martin completed her residency in internal medicine at Boston University Medical Center in 2002.
Martin is a past recipient of the St. George Memorial Cancer Society Fellowship grant to participate in an eight-week clinical fellowship in hematology and oncology and served as treasurer for the society. She was also a teaching associate in medicine at the Boston University School of Medicine.
Dr. Martin is a member of the American Society of Clinical Oncology, American College of Physicians, American Medical Association and American Medical Women's Association.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.